| pubmed-article:2151429 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C1882687 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C0022116 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C0035124 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C1549542 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C1513371 | lld:lifeskim |
| pubmed-article:2151429 | lifeskim:mentions | umls-concept:C0646264 | lld:lifeskim |
| pubmed-article:2151429 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:2151429 | pubmed:dateCreated | 1991-7-22 | lld:pubmed |
| pubmed-article:2151429 | pubmed:abstractText | The aim was to investigate the effects of a newly synthesised bradycardiac agent, FR 76830, on cardiac mechanical function and metabolism during ischaemia and reperfusion. | lld:pubmed |
| pubmed-article:2151429 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2151429 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2151429 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2151429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2151429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2151429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2151429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2151429 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2151429 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2151429 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2151429 | pubmed:issn | 0008-6363 | lld:pubmed |
| pubmed-article:2151429 | pubmed:author | pubmed-author:MatsubaraTT | lld:pubmed |
| pubmed-article:2151429 | pubmed:author | pubmed-author:ImaiSS | lld:pubmed |
| pubmed-article:2151429 | pubmed:author | pubmed-author:NakazawaMM | lld:pubmed |
| pubmed-article:2151429 | pubmed:author | pubmed-author:IshibashiTT | lld:pubmed |
| pubmed-article:2151429 | pubmed:author | pubmed-author:KatsumataNN | lld:pubmed |
| pubmed-article:2151429 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2151429 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:2151429 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2151429 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2151429 | pubmed:pagination | 1008-12 | lld:pubmed |
| pubmed-article:2151429 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:meshHeading | pubmed-meshheading:2151429-... | lld:pubmed |
| pubmed-article:2151429 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2151429 | pubmed:articleTitle | On the mode of cardioprotection produced by a new bradycardic agent, FR 76830, during ischaemia and after reperfusion in the isolated perfused rat heart: a 31P-NMR study. | lld:pubmed |
| pubmed-article:2151429 | pubmed:affiliation | Department of Pharmacology, Niigata University School of Medicine, Japan. | lld:pubmed |
| pubmed-article:2151429 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2151429 | pubmed:publicationType | In Vitro | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2151429 | lld:pubmed |
